#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	810	CRP	633	633	99.53	CRP.l15.c17.ctg.1	1187	36.4	0	.	p	.	0	K29T	NONSYN	85	87	AAG	308	310	ACG	40;41;42	A;C;G	40;41;42	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	T879G	SNP	879	879	T	16	16	G	6	G	5	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	G880A	SNP	880	880	G	17	17	A	7	A	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	A888G	SNP	888	888	A	25	25	G	9	G	8	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	C897G	SNP	897	897	C	34	34	G	17	G	17	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	T898C	SNP	898	898	T	35	35	C	17	C	17	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	G906T	SNP	906	906	G	43	43	T	27	T	27	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	G908A	SNP	908	908	G	45	45	A	30	A	30	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	A918T	SNP	918	918	A	55	55	T	31	T	30	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	A943G	SNP	943	943	A	80	80	G	68	G	67	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	520	Chlamydophila_psittaci_16S	1507	136	91.18	Chlamydophila_psittaci_16S.l15.c30.ctg.3	140	32.9	0	.	n	.	0	G991T	SNP	991	991	G	128	128	T	46	T	46	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1179	1181	AGC	59;60;59	A,G;G;C	37,22;60;58	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	L121Q	0	.	.	361	363	CTG	360	362	CTG	149;144;145	C;T;G	149;143;143	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	Q125R	0	.	.	373	375	CAG	372	374	CAG	141;145;145	C;A;G	141;144;144	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	Q125E	0	.	.	373	375	CAG	372	374	CAG	141;145;145	C;A;G	141;144;144	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	Q125K	0	.	.	373	375	CAG	372	374	CAG	141;145;145	C;A;G	141;144;144	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	Y161D	0	.	.	481	483	TAC	480	482	TAC	149;148;149	T;A;C	148;147;149	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	Y161N	0	.	.	481	483	TAC	480	482	TAC	149;148;149	T;A;C	148;147;149	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	Y161C	0	.	.	481	483	TAC	480	482	TAC	149;148;149	T;A;C	148;147;149	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	G317D	0	.	.	949	951	GGC	948	950	GGC	145;145;137	G;G;C,A	145;145;86,51	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1125	1127	GCA	136;133;133	G;C,A;A	133;125,1;131	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1125	1127	GCA	136;133;133	G;C,A;A	133;125,1;131	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1134	1136	GAA	139;134;135	G;A;A	139;133;133	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	0	HET	.	.	.	C99T	.	99	99	C	98	98	C	82	C,T	48,34	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	0	HET	.	.	.	T135C	.	135	135	T	134	134	T	95	T,C	55,34	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	691	3414	Escherichia_coli_EF_Tu	1185	1184	99.49	Escherichia_coli_EF_Tu.l6.c17.ctg.1	1407	119.8	0	HET	.	.	.	C216T	.	216	216	C	215	215	C	139	C,T	80,57	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1022	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1818	29.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1579	1581	AAA	19;16;16	A;A;A	19;16;16	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1724	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1885	48.5	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1307	1309	GAA	72;72;72	G;A;A	72;72;72	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	308	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	759	21.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1220	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1656	39.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	269	271	CGT	40;43;45	C;G;T	40;42;45	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1220	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1656	39.0	0	.	p	.	0	V30I	NONSYN	88	90	GTC	353	355	ATC	50;49;49	A;T;C	50;49;49	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1220	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1656	39.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1112	1114	GGC	52;52;53	G;G;C	51;52;52	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1802	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2107	45.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	249	251	AGC	18;18;20	A;G;C	18;18;20	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1802	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2107	45.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	651	653	CTA	39;39;39	C;T,A;A	38;38,1;38	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1802	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2107	45.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1170	1172	CAA	48;53;55	C;A;A	48;53;55	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1802	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2107	45.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1269	1271	GGT	101;102;100	G;G;T	101;102;100	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1802	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	2107	45.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1839	1841	GTT	33;33;33	G;T;T	33;33;33	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1594	20.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	560	562	GAA	17;16;17	G;A;A	17;16;17	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1594	20.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	740	742	ACC	17;15;15	A;C;C	17;15;15	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1594	20.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	860	862	ACT	18;17;17	A;C;T	18;17;17	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	600	PmrE	1167	1167	96.83	PmrE.l6.c4.ctg.1	1594	20.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1250	1252	ATC	14;14;16	A;T;C	14;14;16	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	900	PmrF	969	969	99.38	PmrF.l6.c30.ctg.1	1481	32.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	84	TEM_1+	858	304	98.68	TEM_1+.l6.c30.ctg.1	304	5.5	0	.	p	.	0	F19L	NONSYN	55	57	TTT	14	16	CTT	6;6;6	C;T;T	6;6;6	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	84	TEM_1+	858	304	98.68	TEM_1+.l6.c30.ctg.1	304	5.5	0	.	p	.	0	V82I	NONSYN	244	246	GTT	203	205	ATT	4;4;4	A;T;T	4;4;4	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	84	TEM_1+	858	408	99.02	TEM_1+.l6.c30.ctg.2	410	3.4	0	.	p	.	0	H162R	NONSYN	484	486	CAT	106	108	CGT	2;2;2	C;G;T	2;2;2	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	84	TEM_1+	858	408	99.02	TEM_1+.l6.c30.ctg.2	410	3.4	0	.	p	.	0	M261T	NONSYN	781	783	ATG	403	405	ACG	1;1;1	A;C;G	1;1;1	.	TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis;TEM-187
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	1120	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1267	47.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2956	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3528	44.3	0	.	p	.	0	T85I	NONSYN	253	255	ACC	477	479	ATC	42;45;45	A;T,C;C	42;44,1;45	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2956	acrD	3114	3114	99.1	acrD.l15.c30.ctg.1	3528	44.3	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2190	2192	AAG	25;26;26	A;A;G	25;26;26	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1204	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1674	38.1	0	.	p	.	0	A22V	NONSYN	64	66	GCC	307	309	GTC	11;10;11	G;T;C	11;10;11	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1204	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1674	38.1	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1048	1050	TGC	52;54;56	T;G;C	52;53;56	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3038	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3046	52.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	361	361	T	39	T	39	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3038	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3046	52.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	667	669	GAC	71;73;77	G;A;C	70;72;76	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3038	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3046	52.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	943	945	TTA	25;25;27	T;T;A	25;25;27	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3038	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3046	52.5	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1126	1128	AAT	44;43;42	A;A;T	44;43;41	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	3038	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3046	52.5	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1913	1913	T	64	T	63	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	690	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1104	32.9	1	SNP	p	R45C	0	.	.	133	135	CGC	360	362	CGC	44;44;43	C;G;C	44;44;43	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	568	acrS	663	663	98.64	acrS.l15.c17.ctg.1	1006	29.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	270	272	TTC	32;32;32	T;T;C	32;32;32	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	568	acrS	663	663	98.64	acrS.l15.c17.ctg.1	1006	29.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	534	536	GGG	35;35;35	G;G;G	35;35;35	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	724	adiY	762	762	99.61	adiY.l6.c30.ctg.1	1237	31.0	0	.	p	.	0	V136L	NONSYN	406	408	GTT	646	648	CTT	53;51;52	C;T;T	53;51;52	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3082	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3066	53.6	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2059	2061	GCA	81;81;82	G;C;A	81;81;82	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3082	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3066	53.6	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2320	2322	ACC	65;64;63	A;C;C	65;64;63	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	3082	alaS	2631	2631	98.86	alaS.l15.c4.ctg.1	3066	53.6	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2629	2631	GCC	48;50;51	G;C;C	48;49;51	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1440	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2294	32.9	0	.	p	.	0	G37A	NONSYN	109	111	GGT	159	161	GCT	10;11;13	G;C;T	10;11;13	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1440	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2294	32.9	0	.	p	.	0	D77E	NONSYN	229	231	GAT	279	281	GAG	3;3;3	G;A;G	3;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1440	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2294	32.9	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	315	317	TGC	11;12;13	T;G;C	11;12;13	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1440	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2294	32.9	0	.	p	.	0	I150V	NONSYN	448	450	ATT	498	500	GTT	17;18;18	G;T;T	17;18;18	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1440	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2294	32.9	0	.	p	.	0	R200H	NONSYN	598	600	CGC	648	650	CAC	25;25;25	C;A;C	24;24;25	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1440	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2294	32.9	0	.	p	.	0	T295M	NONSYN	883	885	ACG	933	935	ATG	43;43;44	A;T;G	43;43;44	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1440	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2294	32.9	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1929	1931	CGC	28;28;28	C;G;C	28;28;27	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	626	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1251	26.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	901	903	ACC	7;7;6	A;C;C	7;7;6	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	626	bacA	822	822	98.54	bacA.l6.c4.ctg.1	1251	26.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	913	915	TCG	8;8;10	T;C;G	8;8;10	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	618	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1203	27.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1600	33.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1311	1313	AAA	16;16;16	A;A;A	15;16;16	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1600	33.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1323	1325	GAG	11;12;11	G;A;G	11;12;11	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1600	33.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1329	1331	CAC	20;20;20	C;A;C	20;20;20	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1052	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1600	33.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1383	1385	GAG	23;23;23	G;A;G	23;23;23	.	baeS;BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1590	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1803	46.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	890	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1171	40.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	800	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1362	31.1	0	.	p	.	0	A146T	NONSYN	436	438	GCT	644	646	ACT	32;30;30	A;C;T	32;30;30	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	534	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	921	30.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	1202	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1664	38.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	913	915	GTC	67;66;66	G;T;C	65;63;64	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1782	emrB	1539	1539	99.74	emrB.l6.c17.ctg.1	1982	47.8	0	.	p	.	0	E197K	NONSYN	589	591	GAA	804	806	AAA	65;66;66	A;A;A	65;65;65	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1270	emrD	1191	1191	98.4	emrD.l15.c30.ctg.1	1715	39.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	867	869	AGC	32;33;31	A;G;C	32;33;31	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	716	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1341	26.7	0	.	p	.	0	K176R	NONSYN	526	528	AAG	755	757	AGG	26;26;26	A;G;G	26;26;26	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	716	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1341	26.7	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1145	1147	GAC	18;18;18	G;A;C	18;18;18	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	564	emrR	531	531	100.0	emrR.l15.c4.ctg.1	952	31.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1082	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	1986	28.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	462	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1086	22.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	401	403	CTG	44;46;47	C;T;G	44;46;47	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	204	206	AAA	6;7;7	A;A;A	6;6;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	939	941	CAT	24;24;24	C;A;T	24;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	993	995	CAT	36;36;36	C;A;T	36;36;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1011	1013	AGA	27;27;27	A;G;A	26;27;27	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1026	1028	AAT	26;26;24	A;A;T	26;26;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1173	1175	TCC	23;22;21	T;C;C	23;22;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1338	1340	ATT	24;24;25	A;T;T	24;24;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1359	1361	GAT	21;21;21	G;A;T	21;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1473	1475	GTT	32;32;32	G;T;T	32;32;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	2498	97.8	evgS.l15.c30.ctg.1	2663	33.7	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1758	1760	CAC	33;34;32	C;A;C	33;34;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	T38I	NONSYN	112	114	ACA	381	383	ATA	9;7;6	A;T;A	9;7;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	L42V	NONSYN	124	126	CTA	393	395	GTA	11;11;12	G;T;A	11;11;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	A93T	NONSYN	277	279	GCG	546	548	ACG	14;14;15	A;C;G	14;14;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	A114E	NONSYN	340	342	GCA	609	611	GAA	31;31;31	G;A;A	31;31;31	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	T127A	NONSYN	379	381	ACT	648	650	GCT	34;33;33	G;C;T	34;33;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	N133D	NONSYN	397	399	AAT	666	668	GAT	23;23;23	G;A;T	23;23;23	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	P162S	NONSYN	484	486	CCA	753	755	TCA	22;21;20	T;C;A	22;21;20	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	882	884	CAG	16;17;16	C;A;G	16;17;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1020	1022	GTT	13;12;12	G;T;T	13;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	2168	evgS	3594	1043	97.22	evgS.l15.c30.ctg.2	1312	18.7	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1176	1178	GAT	3;3;3	G;A;T	3;3;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	942	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1232	39.7	1	SNP	p	P64A	0	.	.	190	192	CCA	373	375	CCA	80;82;84	C;C;A	80;81;83	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	942	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1232	39.7	1	SNP	p	P64S	0	.	.	190	192	CCA	373	375	CCA	80;82;84	C;C;A	80;81;83	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	942	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1232	39.7	1	SNP	p	P64H	0	.	.	190	192	CCA	373	375	CCA	80;82;84	C;C;A	80;81;83	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	942	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1232	39.7	1	SNP	p	P64L	0	.	.	190	192	CCA	373	375	CCA	80;82;84	C;C;A	80;81;83	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	942	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1232	39.7	1	SNP	p	P64R	0	.	.	190	192	CCA	373	375	CCA	80;82;84	C;C;A	80;81;83	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	506	gadE	528	528	100.0	gadE.l6.c30.ctg.1	1032	25.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	170	gadW	729	149	97.32	gadW.l15.c30.ctg.1	152	21.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	170	gadW	729	171	93.57	gadW.l15.c30.ctg.3	171	5.7	0	.	p	.	0	L31V	NONSYN	91	93	CTG	16	18	GTG	1;1;1	G;T;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	170	gadW	729	171	93.57	gadW.l15.c30.ctg.3	171	5.7	0	.	p	.	0	D34E	NONSYN	100	102	GAT	25	27	GAG	1;1;1	G;A;G	1;1;1	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	170	gadW	729	171	93.57	gadW.l15.c30.ctg.3	171	5.7	0	.	p	.	0	L46P	NONSYN	136	138	CTG	61	63	CCG	3;3;3	C;C;G	3;3;3	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	170	gadW	729	171	93.57	gadW.l15.c30.ctg.3	171	5.7	0	.	p	.	0	E54D	NONSYN	160	162	GAA	85	87	GAT	9;12;12	G;A;T	9;12;12	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	170	gadW	729	150	95.33	gadW.l15.c30.ctg.4	151	12.5	0	.	p	.	0	K110N	NONSYN	328	330	AAA	20	22	AAT	4;4;5	A;A;T	4;4;5	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	548	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1088	26.4	0	.	p	.	0	F53L	NONSYN	157	159	TTC	342	344	TTA	19;19;19	T;T,C;A	19;18,1;19	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	548	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1088	26.4	0	.	p	.	0	V79I	NONSYN	235	237	GTT	420	422	ATT	17;17;18	A;T;T	17;17;18	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	548	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1088	26.4	0	.	p	.	0	R246G	NONSYN	736	738	AGA	921	923	GGA	30;30;29	G;G;A	30;30;29	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	548	gadX	825	825	97.94	gadX.l15.c4.ctg.1	1088	26.4	0	.	p	.	0	S248P	NONSYN	742	744	TCG	927	929	CCG	32;32;32	C;C;G	32;32;31	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2251	2253	GAA	59;62;61	G;A;A	58;62;61	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	S83W	0	.	.	247	249	TCG	466	468	TCG	59;57;57	T;C;G	58;57;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	S83L	0	.	.	247	249	TCG	466	468	TCG	59;57;57	T;C;G	58;57;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	S83I	0	.	.	247	249	TCG	466	468	TCG	59;57;57	T;C;G	58;57;57	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	D87V	0	.	.	259	261	GAC	478	480	GAC	56;57;57	G;A;C	53;54;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	D87H	0	.	.	259	261	GAC	478	480	GAC	56;57;57	G;A;C	53;54;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	D87G	0	.	.	259	261	GAC	478	480	GAC	56;57;57	G;A;C	53;54;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	478	480	GAC	56;57;57	G;A;C	53;54;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2902	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3056	50.3	1	SNP	p	D87N	0	.	.	259	261	GAC	478	480	GAC	56;57;57	G;A;C	53;54;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2870	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2880	52.4	1	SNP	p	R136C	0	.	.	406	408	CGC	669	671	CGC	54;52;52	C;G;C	54;52;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2870	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2880	52.4	1	SNP	p	R136S	0	.	.	406	408	CGC	669	671	CGC	54;52;52	C;G;C	54;52;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2870	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2880	52.4	1	SNP	p	R136I	0	.	.	406	408	CGC	669	671	CGC	54;52;52	C;G;C	54;52;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2870	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2880	52.4	1	SNP	p	R136G	0	.	.	406	408	CGC	669	671	CGC	54;52;52	C;G;C	54;52;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2870	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2880	52.4	1	SNP	p	R136H	0	.	.	406	408	CGC	669	671	CGC	54;52;52	C;G;C	54;52;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2870	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2880	52.4	1	SNP	p	R136L	0	.	.	406	408	CGC	669	671	CGC	54;52;52	C;G;C	54;52;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2870	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	2880	52.4	1	SNP	p	R136E	0	.	.	406	408	CGC	669	671	CGC	54;52;52	C;G;C	54;52;52	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	582	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1099	27.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	431	433	CCG	39;41;42	C;C;G	39;41;42	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	582	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1099	27.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	584	586	GCC	31;31;31	G,T;C;C	30,1;31;31	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1020	leuO	945	945	99.26	leuO.l15.c17.ctg.1	1373	39.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	239	241	TCA	36;38;38	T;C;A	36;38;38	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	344	marA	384	384	99.74	marA.l15.c4.ctg.1	820	22.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	457	459	AGC	15;14;14	A;G;C	15;14;13	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	559	561	CAT	8;8;8	C;A;T	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	V45E	0	.	.	133	135	GTG	283	285	GTG	25;25;24	G;T;G	25;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	I49S	0	.	.	145	147	ATC	295	297	ATC	27;26;26	A;T;C	27;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	A70T	0	.	.	208	210	GCA	358	360	GCA	26;26;26	G;C;A	26;25;26	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	R73C	0	.	.	217	219	CGT	367	369	CGT	25;24;24	C;G;T	24;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	R73S	0	.	.	217	219	CGT	367	369	CGT	25;24;24	C;G;T	24;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	R77L	0	.	.	229	231	CGC	379	381	CGC	18;18;18	C;G;C	18;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	R77C	0	.	.	229	231	CGC	379	381	CGC	18;18;18	C;G;C	18;18;17	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	L78M	0	.	.	232	234	CTG	382	384	CTG	18;18;18	C;T;G	18;17;18	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	R94S	0	.	.	280	282	CGC	430	432	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	R94H	0	.	.	280	282	CGC	430	432	CGC	12;12;12	C;G;C	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	214	marR	435	435	97.7	marR.l15.c30.ctg.1	589	17.5	1	SNP	p	V96E	0	.	.	286	288	GTA	436	438	GTA	14;14;14	G;T;A	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	S7F	NONSYN	19	21	TCC	21	23	TTC	5;5;5	T;T;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	R36I	NONSYN	106	108	AGG	108	110	ATC	16;16;15	A;T;C	15;15;14	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	E42A	NONSYN	124	126	GAA	126	128	GCC	5;6;6	G;C;C	5;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	N43V	NONSYN	127	129	AAT	129	131	GTG	6;5;5	G;T;G	6;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	E52D	NONSYN	154	156	GAG	156	158	GAT	11;11;10	G;A;T	11;11;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	N59T	NONSYN	175	177	AAC	177	179	ACC	11;12;12	A;C;C	11;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	I68L	NONSYN	202	204	ATA	204	206	TTA	10;10;10	T;T;A	10;10;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	345	347	CAG	45;45;43	C;A;G	45;45;43	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	384	386	GCC	22;22;23	G;C;C	22;22;23	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	489	491	GCG	36;37;38	G;C;G	36;37;38	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	693	695	GTT	17;18;17	G;T;T	15;18;15	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	792	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1421	29.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	855	855	C	25	C	25	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.28	mdtA.l15.c30.ctg.1	1510	26.6	0	.	p	.	0	V12trunc	TRUNC	34	34	G	65	65	G	41	G	41	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.28	mdtA.l15.c30.ctg.1	1510	26.6	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	122	124	CAG	13;15;16	C;A;G	13;15;15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.28	mdtA.l15.c30.ctg.1	1510	26.6	0	.	p	.	0	A48V	NONSYN	142	144	GCG	167	169	GTG	15;15;15	G;T;G	15;14;15	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.28	mdtA.l15.c30.ctg.1	1510	26.6	0	.	p	.	0	T83I	NONSYN	247	249	ACC	272	274	ATC	25;25;25	A;T;C	25;25;25	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.28	mdtA.l15.c30.ctg.1	1510	26.6	0	.	p	.	0	I99M	NONSYN	295	297	ATA	320	322	ATG	12;13;14	A;T;G	12;13;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.28	mdtA.l15.c30.ctg.1	1510	26.6	0	.	p	.	0	A130T	NONSYN	388	390	GCC	413	415	ACC	21;21;21	A;C;C	20;21;21	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	794	mdtA	1248	1248	97.28	mdtA.l15.c30.ctg.1	1510	26.6	0	.	p	.	0	P257T	NONSYN	769	771	CCG	794	796	ACG	24;25;24	A;C;G	24;25;24	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2928	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3483	44.6	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1993	1995	ACC	54;57;57	A;C;C	54;56;57	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2928	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3483	44.6	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2386	2388	CAA	37;36;38	C;A;A	33;34;34	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2928	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3483	44.6	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2554	2556	ATT	38;37;37	A;T;T	38;37;37	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2928	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3483	44.6	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2638	2640	GTT	43;43;44	G;T;T	43;43;44	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2928	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3483	44.6	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2746	2748	GAG	31;33;31	G;A;G	31;33;30	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2928	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3483	44.6	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2974	2976	ATG	30;30;31	A;T;G	30;30;31	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2928	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3483	44.6	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3109	3111	GAT	46;47;47	G;A;T	46;47;47	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2682	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3331	42.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	332	334	ATG	32;32;34	A;T;G	32;32;33	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2682	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3331	42.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	818	820	ATC	46;46;46	A;T;C	46;46;46	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2682	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3331	42.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3134	3136	CAC	3;2;2	C;A;C	3;2;2	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2682	mdtC	3078	3078	98.64	mdtC.l6.c17.ctg.1	3331	42.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3137	3139	CTC	2;2;3	C;T;C	2;2;3	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1318	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1843	37.9	0	.	p	.	0	D3E	NONSYN	7	9	GAT	220	222	GAA	18;17;17	G;A;A	18;17;17	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1318	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1843	37.9	0	.	p	.	0	T226A	NONSYN	676	678	ACG	889	891	GCG	53;53;55	G;C;G	53;52;54	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1318	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1843	37.9	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1231	1233	ATC	49;49;48	A;T;C	49;49;48	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1318	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1843	37.9	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1534	1536	TTT	35;35;36	T;T;T	35;35;36	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1604	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1627	52.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3546	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3605	52.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1165	1167	ACC	40;40;42	A;C,A;C	40;37,1;42	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3546	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3605	52.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2407	2409	GAC	62;61;59	G;A;C,T	61;61;58,1	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1120	mdtG	1227	1047	99.33	mdtG.l15.c30.ctg.1	1572	32.8	0	.	p	.	0	V200I	NONSYN	598	600	GTC	640	642	ATC	47;46;47	A;T;C	47;46;47	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1120	mdtG	1227	177	99.44	mdtG.l15.c30.ctg.2	427	13.7	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	3;3;4	G;G;A	3;3;4	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	916	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1546	31.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	587	589	TGT	39;38;37	T;G;T	39;37;37	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	916	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1546	31.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1157	1159	TTG	28;28;26	T;T;G	28;28;25	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	916	mdtH	1209	1209	98.18	mdtH.l6.c17.ctg.1	1546	31.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1367	1369	ACG	11;11;11	A;C;G	11;11;10	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1240	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1820	36.1	0	.	p	.	0	A185S	NONSYN	553	555	GCC	875	877	TCC	33;37;37	T;C;C	31;37;36	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1006	mdtN	1032	1032	98.06	mdtN.l6.c30.ctg.1	1543	34.5	0	.	p	.	0	V119I	NONSYN	355	357	GTT	559	561	ATT	34;34;34	A;T;T	34;34;34	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	V11M	NONSYN	31	33	GTG	198	200	ATG	33;33;33	A;T;G	33;33;33	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	T33I	NONSYN	97	99	ACC	264	266	ATC	27;27;27	A;T;C	27;27;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	C116R	NONSYN	346	348	TGC	513	515	CGC	65;66;61	C;G;C	64;66;61	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	N238S	NONSYN	712	714	AAC	879	881	AGC	44;44;42	A;G;C	44;43;42	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1080	1082	GTG	41;41;41	G;T;G	41;39;41	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1143	1145	AAC	24;24;22	A;A;C	23;23;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1188	1190	GTC	32;33;34	G;T;C	32;33;34	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1218	1220	ATA	63;64;66	A;T;A	63;64;66	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1326	1328	TCT	46;45;44	T;C;T	46;45;44	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1713	1715	GCG	53;54;54	G;C;G	53;53;54	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2140	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2498	45.5	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1926	1928	ATC	39;39;39	A;T;C	39;39;38	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	617	619	GCG	51;50;51	G;C;G	51;49;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	791	793	ACC	46;48;50	A;C;C	46;48;50	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	863	865	CGC	49;50;51	C;G;C	49;50;51	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	980	982	GCT	32;34;34	G;C;T	31;34;34	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1064	1066	AAA	22;22;22	A;A;A	21;22;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1082	1084	CGA	30;29;29	C;G;A	30;28;28	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1247	1249	GCC	32;32;32	G;C;C	32;32;31	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1259	1261	GAT	46;50;48	G;A;T	46;50;48	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	1460	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1896	41.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1676	1678	GCT	6;6;5	G;C;T	6;6;5	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3252	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3912	44.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1545	1547	AAG	36;36;35	A;A;G	36;36;34	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3252	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3912	44.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2622	2624	CTG	52;51;51	C;T;G	52;51;50	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	198	mgrB	144	144	100.0	mgrB.l15.c17.ctg.1	312	22.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1918	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2199	46.4	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1033	1035	AAC	46;47;47	A;A;C	46;45;47	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1918	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2199	46.4	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1579	1581	ATA	57;58;59	A;T;A	57;58;59	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1688	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1724	52.0	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1310	1312	GAT	74;74;72	G;A;T	74;74;72	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1688	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1724	52.0	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1313	1315	CTG	69;66;64	C;T;G	67;65;64	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	275	277	TGT	35;35;36	T;G;T	35;35;36	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	545	547	ACC	30;31;32	A;C;C	30;31;32	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	755	757	GAC	33;33;31	G;A;C	33;33;30	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	1	SNP	p	R15C	0	.	.	43	45	CGC	239	241	CGC	49;48;49	C;G;C	49;48;49	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	1	SNP	p	S33R	0	.	.	97	99	AGC	293	295	AGC	35;35;34	A;G;C	35;34;34	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	1	SNP	p	G131D	0	.	.	391	393	GGC	587	589	GGC	25;24;25	G;G;C	25;23;25	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	1	SNP	p	R203L	0	.	.	607	609	CGT	803	805	CGT	26;23;26	C;G;T	26;23;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	552	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1120	26.0	1	SNP	p	R203C	0	.	.	607	609	CGT	803	805	CGT	26;23;26	C;G;T	26;23;26	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1322	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1515	46.1	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1150	1152	GAG	49;51;50	G;A;G	49;51;50	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1322	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1515	46.1	1	SNP	p	G141E	0	.	.	421	423	GGT	637	639	GGT	62;65;62	G;G;T	62;64;62	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1322	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1515	46.1	1	SNP	p	G141D	0	.	.	421	423	GGT	637	639	GGT	62;65;62	G;G;T	62;64;62	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1322	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1515	46.1	1	SNP	p	R154D	0	.	.	460	462	CGT	676	678	CGT	76;77;80	C;G;T	74;76;80	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1322	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1515	46.1	1	SNP	p	R154A	0	.	.	460	462	CGT	676	678	CGT	76;77;80	C;G;T	74;76;80	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2750	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2723	53.7	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1809	1811	GTG	76;76;77	G;T;G	75;75;77	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2750	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2723	53.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1836	1838	TCG	75;73;71	T;C;G	68;67;68	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2750	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2723	53.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2451	2453	AAC	42;41;43	A;A;C	42;41;42	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2750	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2723	53.7	1	SNP	p	A85T	0	.	.	253	255	GCG	465	467	GCG	72;74;76	G;C;G	72;74;75	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2750	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2723	53.7	1	SNP	p	D111H	0	.	.	331	333	GAT	543	545	GAT	53;53;53	G;A;T	53;53;53	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2750	parC_2	2259	2259	99.2	parC_2.l15.c17.ctg.1	2723	53.7	1	SNP	p	S129P	0	.	.	385	387	TCC	597	599	TCC	47;49;50	T;C;C	47;49;50	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1636	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2454	35.5	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1702	1704	AAC	56;54;55	A;A;C	56;54;55	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1636	parE_1	1893	1893	97.52	parE_1.l15.c30.ctg.1	2454	35.5	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1711	1713	GAT	59;59;59	G;A;T	59;59;59	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1768	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1944	48.1	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	863	865	CAG	42;46;44	C;A;G	42;45;43	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1768	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1944	48.1	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1337	1339	GAT	51;51;50	G;A;T	50;51;50	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	V146F	0	.	.	436	438	GTT	721	723	GTT	58;58;58	G;T;T	58;58;58	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1822	1824	CAG	66;65;64	C;A;G	66;64;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1822	1824	CAG	66;65;64	C;A;G	66;64;63	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1861	1863	CAC	57;57;56	C;A;C	56;57;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1870	1872	CGT	49;48;47	C;G;T	49;48;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1870	1872	CGT	49;48;47	C;G;T	49;48;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1876	1878	TCC	46;44;45	T;C;C	46;44;45	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1882	1884	CTC	43;42;42	C;T;C	43;41;41	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1972	1974	ACC	58;59;57	A;C;C	58;59;56	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1975	1977	CCT	57;59;61	C;C;T	57;59;61	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5222	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4577	60.6	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2344	2346	CGT	99;97;94	C;G;T	99;97;93	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	139	100.0	rrsB+.l15.c30.ctg.1	139	84.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	.	n	.	0	A226G	SNP	226	226	A	368	368	G	468	G	467	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	1	SNP	n	A794T	0	.	.	794	794	A	936	936	A	354	A	347	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	1	SNP	n	A794G	0	.	.	794	794	A	936	936	A	354	A	347	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	1	SNP	n	G926C	0	.	.	926	926	G	1068	1068	G	415	G	415	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	1	SNP	n	G926A	0	.	.	926	926	G	1068	1068	G	415	G	415	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	1	SNP	n	G926T	0	.	.	926	926	G	1068	1068	G	415	G	415	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	C183T	.	183	183	C	325	325	C	368	C,T	266,98	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	A250T	.	250	250	A	392	392	A	413	A,T	313,100	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	T90C	.	90	90	T	232	232	T	359	T,C	246,107	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	G474A,C	.	474	474	G	616	616	G	443	G,A,C	320,121,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	A253T,G	.	253	253	A	395	395	A	410	A,T,G	308,99,2	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	C719T	.	719	719	C	861	861	C	372	C,T	211,161	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	A79G	.	79	79	A	221	221	A	369	A,G	257,110	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	1001	99.9	rrsB+.l15.c30.ctg.2	1143	355.1	0	HET	.	.	.	T273A	.	273	273	T	415	415	T	378	T,A	282,88	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.3	605	403.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	480	480	A	349	A	348	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.3	605	403.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	480	480	A	349	A	348	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	503	100.0	rrsB+.l15.c30.ctg.3	605	403.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	480	480	A	349	A	348	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	72.9	0	.	n	.	0	G1002A	SNP	1002	1002	G	54	54	A	140	A	140	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	72.9	0	.	n	.	0	G1006C	SNP	1006	1006	G	58	58	C	146	C,G	145,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	72.9	0	.	n	.	0	T1010C	SNP	1010	1010	T	62	62	C	148	C,T	145,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	72.9	0	.	n	.	0	A1019.	DEL	1019	1019	A	70	70	G	146	G	146	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	72.9	0	.	n	.	0	.1023G	INS	1023	1023	T	75	75	G	142	G	142	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	13250	rrsB+	1542	141	95.07	rrsB+.l15.c30.ctg.4	141	72.9	0	.	n	.	0	C1038T	SNP	1038	1038	C	90	90	T	121	T	121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	794	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1013	41.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	630	soxR	465	465	100.0	soxR.l15.c4.ctg.1	844	39.3	1	SNP	p	R20H	0	.	.	58	60	CGC	247	249	CGC	60;62;62	C;G;C	60;61;62	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	630	soxR	465	465	100.0	soxR.l15.c4.ctg.1	844	39.3	1	SNP	p	G121D	0	.	.	361	363	GGT	550	552	GGT	40;39;40	G;G;T	40;39;40	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	422	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	860	26.0	1	SNP	p	A12S	0	.	.	34	36	GCA	286	288	GCA	62;62;61	G;C;A	62;61;61	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	9410	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c30.ctg.1	1343	372.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	10014	APH_6__Id+	837	837	100.0	APH_6__Id+.l6.c30.ctg.1	1376	387.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	6994	sul2	816	816	100.0	sul2.l6.c30.ctg.1	1285	288.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	10548	tetA	1200	1200	100.0	tetA.l15.c17.ctg.1	1662	335.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	6614	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1216	288.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1726	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	1993	46.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
